Management of hypertension and hypercholesterolaemia in primary care in the Netherlands

References

• World Health Organization. The World Health Report 2003. Shaping the Future. Geneva: World Health Organization, 2003
   Google Scholar
• Thomas F, Bean K, Guize L, et al. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (< 55 years) men and women. Eur Heart J 2002;23:528–35
   PubMed Web of Science ®Google Scholar
• Turnbull F. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527–35
   Google Scholar
• Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ 2000;321:938–6
   Google Scholar
• Klungel OH, de Boer A, Paes AH, et al. Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens 1998;16:1371–8
   PubMed Web of Science ®Google Scholar
• Klungel OH, Stricker BH, Paes AH, et al. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999;30:1312–8
   PubMed Web of Science ®Google Scholar
• EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995–1001
   Google Scholar
• Boersma E, Keil U, De Bacquer D, et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003;21:1831–40
   PubMed Web of Science ®Google Scholar
• Bottorff MB. Underidentification and undertreatment issues. J Manag Care Pharm 2003;9(Suppl):6–8
   Google Scholar
• Devroey D, Betz W, Kartounian J. An evaluation of pharmaceutical treatment of dyslipidaemia among patients without diagnosed atherosclerotic disease in Belgium. Int J Clin Pract 2003;57:720–5
   Google Scholar
• Mantel-Teeuwisse AK, Verschuren WM, Klungel OH, et al. Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol 2003;55:389–97
   PubMed Web of Science ®Google Scholar
• Wright DJ, Grayson AD, Jackson M, et al. The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey. Int J Clin Pract 2003;57:488–91
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10–7
   PubMed Web of Science ®Google Scholar
• Schelleman H, Klungel OH, Kromhout D, et al. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens 2004;18:317–24
   PubMed Web of Science ®Google Scholar
• Mantel-Teeuwisse AK. Quality and safety aspects of lipid-lowering drug use. Utrecht: University of Utrecht; 2004
   Google Scholar
• Geijer R, Burger J, Van der Laan J, et al. NHG-standaarden voor de huisarts. In: Maarsen: Elsevier/Bunge; 1999, pp. 187–205
   Google Scholar
• Thomas S, Van der Wijden T, et al. NHG-Standaard Cholesterol. Huisarts en Wetenschap 1999;42:406–17
   Google Scholar
• Walma E, Thomas S, Prins A, et al. NHG-standaard Hypertensie (NHG standard hypertension). Huisarts en Wetenschap 2003;46:435–49
   Google Scholar
• Van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in The Netherlands. Ann Intern Med 1993;119:1036–41
   PubMed Web of Science ®Google Scholar
• Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999;38:339–44
   PubMed Web of Science ®Google Scholar
• Lamberts H, Wood M. International Classification of Primary Care. Oxford: Oxford University Press, 1987
   Google Scholar
• Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293–8
   PubMed Web of Science ®Google Scholar
• Vliet AL, Van den Hof S, Elvers LH, et al. Risicofactoren En Gezondheids Evaluatie Nederlandse Bevolking, een Onderzoek op GGD’en, jaarverslag 2001. Bilthoven: RIVM, 2001. Report No: 260854004/2003
   Google Scholar
• Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151–83
   Google Scholar
• Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care 2001;39\(Suppl 2):II46–54
   Google Scholar
• Grol R, Dalhuijsen J, Thomas S, et al. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998;317:858–61
   PubMed Web of Science ®Google Scholar
• Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458–65
   PubMed Web of Science ®Google Scholar
• McAlister FA, Campbell NR, Zarnke K, et al. The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ 2001;164:517–22
   PubMed Web of Science ®Google Scholar
• Kedward J, Dakin L. A qualitative study of barriers to the use of statins and implementation of coronary heart disease prevention in primary care. Br J Gen Pract 2003;53:684–9
   PubMed Web of Science ®Google Scholar
• EUROASPIRE Study Group. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997;18:1569–82
   Google Scholar
• Lemaitre RN, Furberg CD, Newmann AB, et al. Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med 1998;158:1761–8
   PubMed Web of Science ®Google Scholar
• Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000;321:1322–5
   PubMed Web of Science ®Google Scholar
• Abookire SA, Karson AS, Fiskio J, et al. Use and monitoring of ‘statin’ lipid-lowering drugs compared with guidelines. Arch Intern Med 2001;161:53–8
   PubMed Web of Science ®Google Scholar
• van Dam M, van Wissen S, Kastelein JJ. Declaring war on undertreatment: rationale for an aggressive approach to lowering cholesterol. J Cardiovasc Risk 2002;9:89–95
   PubMedGoogle Scholar
• Vale MJ, Jelinek MV, Best JD; COACH study group. Coaching patients on Achieving Cardiovascular Health. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996–1998 versus 1999–2000. Med J Aust 2002;176: 211–5
   Google Scholar
• Heidrich J, Liese AD, Kalic M, et al. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Munster, Germany] [Article in German]. Dtsch Med Wochenschr 2002;127:667–72
   PubMed Web of Science ®Google Scholar
• Natarajan S, Nietert PJ. National trends in screening, prevalence, and treatment of cardiovascular risk factors. Prev Med 2003;36:389–97
   PubMed Web of Science ®Google Scholar
• de Lusignan S, Dzregah B, Hague N, et al. Cholesterol management in patients with IHD: an audit-based appraisal of progress towards clinical targets in primary care. Br J Cardiol 2003;10:223–8
   Google Scholar
• Pyörälä K, Lehto S, De Bacquer D, et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia 2004;47:1257–65
   Google Scholar
• Primatesta P, Poulter NR. Lipid levels and the use of lipid-lowering agents in England and Scotland. Eur J Cardiovasc Prev Rehabil 2004;11:484–8
   PubMed Web of Science ®Google Scholar
• Primatesta P, Poulter NR. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 2004;22:1093–8
   PubMed Web of Science ®Google Scholar
• Ornstein SM, Nietert PJ, Dickerson LM. Hypertension management and control in primary care: a study of 20 practices in 14 states. Pharmacotherapy 2004;24: 500–7
   Google Scholar